Kesar Pharma Profile
Key Indicators
- Authorised Capital ₹ 6.90 Cr
- Paid Up Capital ₹ 3.45 Cr
- Company Age 13 Year, 4 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 11.52 Cr
- Satisfied Charges ₹ 7.65 Cr
- Revenue Growth 9.44%
- Profit Growth 51.01%
- Ebitda -1.50%
- Net Worth 129.90%
- Total Assets -4.11%
About Kesar Pharma
Kesar Pharma Limited (KPL) is a leading Public Limited Indian Non-Government Company incorporated in India on 18 October 2011 and has a history of 13 years and four months. Its registered office is in Gandhi Nagar, Gujarat, India.
The Corporate was formerly known as Kesar Swasthya Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 6.90 Cr and a paid-up capital of Rs 3.45 Cr.
The company currently has active open charges totaling ₹11.52 Cr. The company has closed loans amounting to ₹7.65 Cr, as per Ministry of Corporate Affairs (MCA) records.
Prakash Patel, Kalpesh Shah, and Parth Parikh serve as directors at the Company.
Company Details
- Location
Gandhi Nagar, Gujarat, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
- Social Media
Corporate Identity Details
- CIN/LLPIN
U24239GJ2011PLC067520
- Company No.
067520
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
18 Oct 2011
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
What products or services does Kesar Pharma Limited offer?
Kesar Pharma Limited offers a wide range of products and services, including Pain Relief Drugs & Pharmaceuticals, Arthritic Drugs, Anti Infective Drugs & Medicines, Antiviral Drugs, Malaria Medicine, Antibiotic Tablets, Capsule & Syrup, TB, Tumor & Cancer Drugs, Anti Cancer Medicines, Antibacterial Drugs.
Who are the key members and board of directors at Kesar Pharma?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Prakash Patel  | Director | 18-Oct-2011 | Current |
| Kalpesh Shah | Director | 01-May-2014 | Current |
| Parth Parikh | Director | 06-Sep-2019 | Current |
Financial Performance of Kesar Pharma.
Kesar Pharma Limited, for the financial year ended 2024, experienced modest growth in revenue, with a 9.44% increase. The company also saw a substantial improvement in profitability, with a 51.01% increase in profit. The company's net worth Soared by an impressive increase of 129.9%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Kesar Pharma?
In 2024, Kesar Pharma had a promoter holding of 100.00%. The company had 1 Subsidiary. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Kesar Finechem Private LimitedPrakash Patel, Kalpesh Shah and 1 more are mutual person
- Hapax Pharma Private Limited
Prakash Patel and Kalpesh Shah are mutual person
- Janki Windfarm Developers Private Limited
Prakash Patel is a mutual person
- Dove Resources Private Limited
Prakash Patel is a mutual person
- Vipronova Lifescience Private Limited
Parth Parikh is a mutual person
- Meghdhanush Drones & Agro Technologies Private Limited
Parth Parikh is a mutual person
Charges (Loans)
₹11.52 Cr
₹7.65 Cr
Charges Breakdown by Lending Institutions
- Others : 8.99 Cr
- Sidbi : 2.53 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Feb 2024 | Sidbi | ₹1.40 Cr | Open |
| 28 Mar 2023 | Sidbi | ₹6.28 M | Open |
| 06 Feb 2021 | Others | ₹5.50 M | Open |
| 07 Sep 2020 | Others | ₹1.44 Cr | Open |
| 27 Apr 2020 | Sidbi | ₹5.00 M | Open |
How Many Employees Work at Kesar Pharma?
Kesar Pharma has a workforce of 47 employees as of Feb 24, 2025. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kesar Pharma, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kesar Pharma's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
